Developing Meds in Space to Save Lives on Earth

A session at SXSW Interactive 2013

Tuesday 12th March, 2013

9:30am to 10:30am (CST)

NASA and various international space agencies have spent an estimated $100 billion on the development and construction of the ISS . The ISS was envisioned as being an on-orbit microgravity laboratory “that will make valuable products in space to improve and save lives on earth” . Astrogenetix, Inc. was formed in 2007 to commercialize on the many discoveries that were, and can be made in microgravity.

The ISS was designated as a national laboratory in 2005 opening up the research facilities of the orbiting laboratory to commercial and academic partners. This official designation enabled the Company to enter into a Space Act Agreement (SAA) with NASA in 2008 providing Astrogenetix, until 2016, with access to and from the ISS while having the right to use ISS resources, including, but not limited to, crew time, power, equipment, rack space and data downlink, for the purpose of conducting experiments in microgravity to produce commercial products here on earth.

About the speaker

This person is speaking at this event.
Thomas Pickens

CEO, Astrotech Corporation

Next session in Ballroom BC

11am Work Sucks, but Your RFP Doesn't Have To by Zach Chandler, Todd Nienkerk, Crystal Williams and Julienne Vanderziel

1 attendee

  • Thomas B. Pickens III

Sign in to add slides, notes or videos to this session

Sign in to track this session

Tell your friends!


Time 9:30am10:30am CST

Date Tue 12th March 2013


Ballroom BC, Austin Convention Center

Session type

Solo / Dual / Panel

Session Hash Tag


Short URL


View the schedule



See something wrong?

Report an issue with this session